StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
052260.KQ$3770.00+0.00%
Fair $3770.00+0.0%

052260.KQ

HYUNDAI BIOLAND Co.,Ltd.

Unknown / UnknownKOSDAQ

$3770.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $3770.00Fund rank 29/100 · Data gapFallback financials|
SA 44/C
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 21%

FCF escenarios

weak_data · normalized FCF $676.4M · quality 51.7/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 25/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

44/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 0.2%, below the 5% threshold
Thesis & Journal · 052260.KQLocal privado en este navegador · HYUNDAI BIOLAND Co.,Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$113.1B

P/E

471.3x

↑

EV/EBITDA

6.3x

↓

ROE

0.2%

↓

Gross Margin

41.0%

↑

Debt/Equity

0.08

↓
52-Week Range$3770
$3690$5420

TradingView lightweight chart

052260.KQ price, volumen y niveles de valoración

Último $3,770Periodo -3.8%
Fair value: $3,770

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+9.6%

FCF CAGR

+32.9%

FCF margin

11.8%

FCF / Net income

60.99x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $130.51B · net income $252.6M · FCF $15.41B

2022-FY → 2025-FY

Gross margin

41.0%+5.1% pts

Operating margin

9.8%+0.6% pts

Net margin

0.2%-4.6% pts

FCF margin

11.8%+5.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$130.51B$130.51B$119.52B$96.72B$99.15B
Net Income$252.6M$252.6M$5.70B$8.06B$4.76B
EBITDA$17.70B$17.70B$22.90B$24.30B$14.45B
EPS8.008.00190.00134.00159.00
Gross Margin41.0%41.0%44.2%41.1%36.0%
Operating Margin9.8%9.8%13.7%13.9%9.1%
Net Margin0.2%0.2%4.8%8.3%4.8%
Balance Sheet
Debt/Equity0.080.080.260.240.27
Cash Flow
Free Cash Flow$15.41B$15.41B$676.4M$-702.7M$6.56B
Returns
ROE0.2%0.2%4.1%5.9%3.7%
Valuation
P/E471.25471.2523.4775.9782.70
EV/EBITDA6.316.316.4713.3729.20
P/B0.870.870.972.253.05
Growth & Yield
Revenue Growth9.2%9.2%23.6%-2.5%—
EPS Growth-95.8%-95.8%41.8%-15.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

247.1%

muy exigente

EPS terminal req.

$334.52

Spread vs growth

-342.9%

5Y implied EPS CAGR

119.2%

muy exigente

EPS terminal req.

$404.77

Spread vs growth

-215.0%

10Y implied EPS CAGR

55.3%

muy exigente

EPS terminal req.

$651.89

Spread vs growth

-151.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -12.4%

Total return

-12.4%

Start / end P/E

22.7x → 471.3x

EPS bridge

190.00 → 8.00

Residual

-1896.5%

EPS growth-95.8%
Multiple rerating+1979.8%
Dividend+0.0%
Residual / FX / buybacks / cross-term-1896.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.